16 Sep 2011
In the US when the vaccine was first recommended for adolescents in 2005, the expectation was that protection would last for 10 years; however, currently available data suggest it wanes in most adolescents within 5 years. Based on that information, a single dose at the recommended age of 11 or 12 years may not offer protection through the adolescent years at which risk for meningococcal infection is highest (16 though 21 years of age). A booster dose is now recommended at age 16.
- Meningococcal Polysaccharide Vaccine Information for Consumers
- Meningococcal Polysaccharide Vaccine Information for Healthcare Professionals (includes dosage details)
- Side Effects of Meningococcal Polysaccharide Vaccine (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Rotavirus Vaccine - my child has been given rotarix vaccine 1st dose. now the vaccine is unavailable
... and its reaching 6 month period. is there any side effects if the vaccine 2nd oral dose is not administered or whether the vaccine can be given ...
1 answer • 22 Mar 2010
... received help me to resist pneumonia?
1 answer • 22 Jul 2010
... having any fever but blood tests showed high infection . later csf samples confirmed decease i m worried abt consequences pls guide me , her ...
2 answers • 9 Feb 2012
what will happens when measles vaccine administered through intradermal or intermuscular?
1 answer • 17 Sep 2013
... rashes have occured over her skin. So, is it safe & how long it will remaining?
0 answers • 20 Jun 2014